News

Funding round

Together we’re developing hybrid quantum–classical methods to boost protein–ligand modeling, combining PharmAI’s AI-driven discovery with TU Dresden’s quantum expertise. (18 Sep 2025)

Funding round

PharmAI Discovery Secures €5 Million to Accelerate AI-Powered Drug Pipeline (26 Feb 2025)

APPEAL Project

PharmAI Discovery Joins EU-Funded APPEAL Project to Fast-Track Host-Targeted Antivirals (May 2025)

Enamine & Chemspace partnership

PharmAI Discovery Partners with Enamine & Chemspace to Expand AI-Driven Theranostic Pipeline

LDH patent

PharmAI Discovery Files Two Patent Families for LDH-Tetramer Disruptors, Opening a New Front in Cancer Metabolism (Oct 2024)

HSP27 inhibitors

AI-Designed HSP27 Neuro-Protective Inhibitors Advance Toward Pre-Clinical GLP Studies at PharmAI Discovery